Targeting disease activity to predict and prevent damage in obstructive airway diseases

Area of Science:

• Pulmonary Medicine
• Biomarker Discovery
• Disease Management

Background:

• Clinically accessible biomarkers now identify patients with obstructive airway disease at risk of adverse outcomes.
• Highly effective targeted treatments for obstructive airway diseases are increasingly available.
• This creates an opportunity for earlier intervention and disease modification.

Purpose of the Study:

• To advocate for a paradigm shift in obstructive airway disease management.
• To propose a new framework focusing on 'high risk disease' (high disease activity) rather than 'too late disease' (disease-related damage).
• To review supporting evidence, identify knowledge gaps, and discuss implementation strategies.

Main Methods:

• Literature review of current evidence on obstructive airway disease biomarkers and treatments.
• Analysis of the 'high risk disease' concept versus traditional 'too late disease' models.
• Discussion of practical opportunities for operationalizing the proposed framework.

Main Results:

• Evidence supports a move towards proactive identification of high disease activity.
• Current approaches often focus on established disease-related damage, representing a 'too late disease' scenario.
• Gaps in evidence and implementation strategies need to be addressed.

Conclusions:

• The current landscape of biomarkers and treatments necessitates a shift towards early, proactive intervention in obstructive airway disease.
• Adopting a 'high risk disease' framework can optimize patient outcomes by enabling timely, targeted therapies.
• Further research and strategic planning are required to operationalize this new management paradigm.